BioMedMarket.Info

Israel-based non-profit Global Forum for Research, Technology, Law, News and Ideas on BioMedical Sciences

_  Press go button to open Subscription Request form for BioMedMarket biweekly news alerts  This link leads to About BioMedMarket.Info page        
Visit Google Scholar, new search of peer reviewed quality scholar literature by Google _

Saturday, April 23, 2005

Israeli Home Test kKt for Abnormal Vaginal Discharges Approved by FDA

Apr. 17, 2005 - Caesarea-based Common Sense Ltd. has received the US Food and Drug Administration's (FDA ) approval to begin the immediate distribution of its VI-SENSE Kit in the US, YnetNews reported. The VI-SENSE Kit is a non-intrusive home test for classification of common abnormal vaginal discharges. It uses a wafer-thin panty liner with a removable indicator strip, which is impregnated with a fully patented chemical composition that changes color when it comes into contact with an abnormal vaginal discharge. The test is especially sensitive to high acid levels, which are symptomatic of infections that require antibiotic treatment. In 2003 the company began marketing the VI-SENSE Kit in Europe, where some 75 million cases of irregular vaginal discharge are reported each year. The product received the CE mark (European standard), and is currently being sold in 15 European countries.


Source: Israel21c.org news for April 17-23, 2005 [FullText]
_ _  Please review the terms of BioMedMarket.Info News alerts        
Visit Google Scholar, new search of peer reviewed quality scholar literature by Google _